Metabolic syndrome and major depression
- 8 October 2013
- journal article
- review article
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 19 (4), 293-304
- https://doi.org/10.1017/s1092852913000667
Abstract
Major depression is associated with a 4-fold increased risk for premature death, largely accounted by cardiovascular disease (CVD). The relationship between depression and CVD is thought to be mediated by the so-called metabolic syndrome (MeS). Epidemiological studies have consistently demonstrated a co-occurrence of depression with MeS components, ie, visceral obesity, dyslipidemia, insulin resistance, and hypertension. Although the exact mechanisms linking MeS to depression are unclear, different hypotheses have been put forward. On the one hand, MeS could be the hallmark of the unhealthy lifestyle habits of depressed patients. On the other, MeS and depression might share common alterations of the stress system, including the hypothalamus-pituitary-adrenal (HPA) axis, the autonomic nervous system, the immune system, and platelet and endothelial function. Both the conditions induce a low grade chronic inflammatory state that, in turn, leads to increased oxidative and nitrosative (O&NS) damage of neurons, pancreatic cells, and endothelium. Recently, neurobiological research revealed that peripheral hormones, such as leptin and ghrelin, which are classically involved in homeostatic energy balance, may play a role in mood regulation. Metabolic risk should be routinely assessed in depressed patients and taken into account in therapeutic decisions. Alternative targets should be considered for innovative antidepressant agents, including cytokines and their receptors, intracellular inflammatory mediators, glucocorticoids receptors, O&NS pathways, and peripheral mediators.Keywords
This publication has 98 references indexed in Scilit:
- Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based studyJournal of Affective Disorders, 2012
- Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesityJournal of Affective Disorders, 2011
- Association between adolescent emotional problems and metabolic syndrome: The modifying effect of C-reactive protein gene (CRP) polymorphismsBrain, Behavior, and Immunity, 2011
- Depressive symptoms and metabolic risk: Effects of cortisol and genderPsychoneuroendocrinology, 2009
- Depressive symptoms and the metabolic syndrome in childhood and adulthood: A prospective cohort study.Health Psychology, 2009
- Depressive Symptoms and Metabolic Syndrome: Is Inflammation the Underlying Link?Biological Psychiatry, 2008
- The orexigenic hormone ghrelin defends against depressive symptoms of chronic stressNature Neuroscience, 2008
- Metabolic syndrome is associated with self-perceived depressionScandinavian Journal of Primary Health Care, 2008
- The leptin hypothesis of depression: a potential link between mood disorders and obesity?Current Opinion in Pharmacology, 2007
- Hypercortisolemic depression is associated with the metabolic syndrome in late-lifePsychoneuroendocrinology, 2007